| Income Statement |
| Operating Expenses | 4.78M |
|
| Research and Development Expense | 3.21M |
| Selling, General and Administrative Expense | 1.57M |
| Operating Income | -4.78M |
| Income Tax Expense | -410.00K |
| Net Income | -3.86M |
| Net Income Common Stock | -3.86M |
| Net Income Common Stock (USD) | -5.15M |
| Consolidated Income | -3.86M |
| Earning Before Interest & Taxes (EBIT) | -4.28M |
| Earning Before Interest & Taxes (USD) | -5.70M |
| Weighted Average Shares | 20.81B |
| Balance Sheet |
| Cash and Equivalents | 21.53M |
| Cash and Equivalents (USD) | 28.71M |
| Current Assets | 24.57M |
| Property, Plant & Equipment Net | 641.00K |
| Total Assets | 27.55M |
| Debt Current | 33.00K |
| Total Debt | 680.00K |
| Current Liabilities | 4.48M |
| Debt Non-Current | 647.00K |
| Total Liabilities | 5.19M |
| Accumulated Retained Earnings (Deficit) | -251.17M |
| Shareholders Equity | 22.37M |
| Shareholders Equity (USD) | 29.82M |
| Assets Non-Current | 2.99M |
| Total Debt (USD) | 906.67K |
| Goodwill and Intangible Assets | 2.22M |
| Liabilities Non-Current | 705.00K |
| Trade and Non-Trade Payables | 673.00K |
| Tax Assets | 2.29M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 68.00K |
| Net Cash Flow from Financing | -7.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.12M |
| Issuance (Repayment) of Debt Securities | -7.00K |
| Net Cash Flow from Investing | 72.00K |
| Net Cash Flow from Operations | -3.18M |
| Effect of Exchange Rate Changes on Cash | 395.00K |
| Share Based Compensation | 1.89M |